The Food and Drug Administration has approved its first digital drug: a pill embedded with a sensor that transmits whether someone has taken it. Although the approval is a big step for digital medicine, there are concerns about privacy, convenience and cost. The tablet and embedded sensor is called Abilify MyCite. Abilify, made by Japan-based Otsuka Pharmaceutical, is the brand-name version of aripiprazole , an antipsychotic drug used for treating schizophrenia, bipolar disorder and as an add-on treatment for depression in adults. The tiny sensor , made by a company called Proteus, is about the size of a grain of sand. It's activated when it comes into contact with fluid in the stomach. The sensor detects and records the date and time the pill is...
READ MORE >
FDA Approves First Digital Pill That Can Track Whether You've Taken It